News | News By Subject | News by Disease News By Date | Search News

Lung cancer News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AstraZeneca PLC (AZN) Stock Hits 2017 High as Lung Cancer Med Reduces Death Risk in Phase III Study     5/15/2017
Catastrophic Year for Bay Area's OncoMed (OMED) Continues as Lead Drug Comes Crashing Down in Phase II Study     5/9/2017
Takeda (TKPYY)'s $5 Billion Bet on Ariad (ARIA) Pays Off With Accelerated Approval of Lung Cancer Med     5/1/2017
The FDA Calls Pfizer (PFE)’s Next-Generation Lung Cancer Drug a Breakthrough     4/28/2017
AstraZeneca PLC (AZN)'s Lung Cancer Trial Gets Delayed     4/27/2017
When It Rains, It Pours: Bay Area's OncoMed (OMED) Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study     4/18/2017
How This Drug Candidate Could be a Winner in Gilead (GILD)'s Pipeline     3/23/2017
Heat Biologics (HTBX) Rockets as Lung Cancer Med Hits Mid-Stage Goals     3/22/2017
Genentech (RHHBY)'s $94,000-a-Year Drug Tarceva: Why Faster FDA Approvals Could Backfire     2/8/2017
The 7 Worst Clinical Disasters of 2016     12/27/2016
Concordia (CXR.TO) Kills Phase III Trial, Terminates Contract Sales, and Leaves Nasdaq Biotech Index     12/19/2016
Bristol-Myers Squibb (BMY) Looks Over Its Shoulder as Opdivo Disappoints While Merck & Co. (MRK)'s Keytruda Shines in Lung Cancer Study     10/10/2016
Genentech (RHHBY)’s Lung Cancer Drug Alecensa Gets 2nd FDA Breakthrough Status     10/5/2016
This Biotech Has the Upper Hand Over Allergan (AGN) and Gilead (GILD) in the Heated Nash Battle     9/23/2016
FDA Grants Priority Review and Breakthrough Tag for Merck & Co. (MRK)’s Keytruda     9/7/2016

News from Around the Web
New Blood Test Could Treat Non-Small-Cell Lung Cancer Faster, The Journal of Molecular Diagnostics Reveals     4/19/2017
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug     2/17/2017
Liquid Biopsy For Lung Cancer Provides Rapid Results At Low Cost And No Trauma, Stanford University Study     1/6/2017
Czech Scientists Develop Human Lung Model To Aid Treatments, Brno University Of Technology Study     11/29/2016
Balance Of Power Shifts With Merck & Co. (MRK)'s Keytruda First-Line Therapy Approval In Lung Cancer     10/26/2016
Genentech (RHHBY)’s Tecentriq Wins Second Approval of the Year, This Time for Lung Cancer     10/19/2016
AI Beats Doctors At Visual Diagnosis, Observes Many Times More Lung Cancer Signals, Stanford University Study     8/19/2016
Transgenomic, Inc. (TBIO) Launches First Commercially Available CLIA Test For Detection Of EGFR C797S Mutations That Predict Resistance To 3rd Generation Kinase Therapies For Lung Cancer     7/25/2016
University of Louisville Teams Up With Company To Help Lung Cancer Diagnosis     6/15/2016
This Diet Ups Your Lung Cancer Even If You Don't Smoke, MD Anderson Cancer Center Study     3/9/2016
Biotech Startup Yihuo Bio To Produce New Device For Early Detection Of Lung Cancer     2/29/2016
Could A Lung Cancer Drug Work Better With Coke? Erasmus MC Study     2/16/2016
This Lung Cancer Drug May Not Be What It Seems, Chemists Say     1/4/2016
Study Suggests Indi's Xpresys Test Could Reduce Invasive Procedures In NSCLC Diagnosis     12/23/2015
A New Way To Test For Rejection or Infection Following Lung Transplantation, Stanford University Study     10/15/2015

Press Releases
Circulogene Theranostics Expands Liquid Biopsy Testing Capabilities, Adds Three sfRNA-Based NSCLC Tests Supporting Personalized Treatment For Lung Cancer Patients     5/23/2017
Novartis AG (NVS) Receives Positive CHMP Opinion For First-Line Use Of Zykadia In ALK-Positive Advanced Non-Small Cell Lung Cancer (NSCLC)     5/19/2017
Syndax Announces Advancement Of ENCORE 601 In Non-Small Cell Lung Cancer Patients With Disease Progression On Or After PD-1 Therapies     5/17/2017
FDA Clears Body Vision's LungVision Navigation System, Revolutionizing Lung Cancer Detection and Treatment     5/16/2017
Astellas (ALPMY) Dumps Lung Cancer Program After Phase III Data Fails To Impress     5/11/2017
Bristol-Myers Squibb (BMY) And Calithera Biosciences (CALA) Expand Collaboration Evaluating Opdivo (Nivolumab) In Combination With CB-839 Into Non-Small Cell Lung Cancer And Melanoma     5/10/2017
AstraZeneca Canada (AZN) Release: Pan-Canadian Oncology Drug Review Recommendation Supports The Use Of Tagrisso (Osimertinib) As The Standard Of Care For T790M Mutated Non-Small Cell Lung Cancer     5/8/2017
Epic Sciences And Collaborators Publish Study On New Blood Test Showing Expression Of PD-L1 On Circulating Cells Is Associated With Worse Outcomes In Lung Cancer Patients Not Treated With PD-1 Inhibitors     5/8/2017
Cancer Genetics (CGIX) Changes The Paradigm For Lung Cancer Monitoring – Launches Clinically Actionable, Multi-Gene, Liquid Biopsy Test For Lung Cancer Patients, Liquid::Lung-CfDNA     5/8/2017
European Society For Medical Oncology (ESMO) - Osimertinib Improves Symptoms In Advanced Lung Cancer Patients     5/5/2017
European Society For Medical Oncology (ESMO) - White Blood Cell Count Predicts Response To Lung Cancer Immunotherapy     5/5/2017
Study In Nature Shows Early Relapse Detection In Lung Cancer Using Natera's Technology For ctDNA Analysis     4/27/2017
First Patient Treated In Turnstone Biologics's Lung Cancer Trial Combining Novel Viral Cancer Therapy With Approved Checkpoint Inhibitor     4/26/2017
TRANSGENE (ENX:TNG) And Bristol-Myers Squibb (BMY) Announce Clinical Research Collaboration To Evaluate TG4010 In Combination With Opdivo And Standard Chemotherapy In First Line Non-Small Cell Lung Cancer     4/25/2017
Mologen (MOLGF.PK): Positive Subgroup Results Of The Exploratory Phase II IMPULSE Study Of Lefitolimod In Extensive-Disease Small-Cell Lung Cancer (SCLC)     4/24/2017

//-->